Development Protein A (DPA) is a novel therapeutic biologic designed for inhaled administration. In phase I clinical studies, the DPA solution is administered using a continuous-output nebulizer. In ...

About YUTREPIA™ (treprostinil) Inhalation Powder YUTREPIA is an inhaled dry-powder formulation of treprostinil delivered through a convenient, low-effort, palm-sized device.

Liquidia's accused product, Yutrepiaä, is also a dry powder formulation of treprostinil approved by FDA on August 19, 2024.

Liquidia announces FDA approval and commercial launch of YUTREPIA for treating pulmonary arterial hypertension and PH-ILD.

YUTREPIA is an inhaled dry-powder formulation of treprostinil delivered through a convenient, low-effort, palm-sized device. YUTREPIA was designed using Liquidia’s PRINT® technology, which enables the ...

Meeting the Growing Demand for Dry Powder Inhaler Delivery. To successfully bring DPIs to market, key milestones must be achieved. The quickest way to meet these demands is to start with the simplest ...

About YUTREPIA™ (treprostinil) Inhalation Powder YUTREPIA is an investigational, inhaled dry-powder formulation of treprostinil delivered through a convenient, low-effort, palm-sized device.

The researchers found that dry powder triple inhaler therapy of fluticasone-umeclidinium-vilanterol resulted in fewer COPD exacerbations compared to metered dose triple inhaler therapy of ...

The dry powder dais has equipment that produce aerosol directly from pharmaceutical blends or powder with active ingredients in sizes ranging from 1–5 microns. The ingredients utilised in dry powder ...

MNKD-201, an inhaled formulation of nintedanib for IPF, was shown to be safe and well tolerated in a clinical trial with healthy volunteers.

Agreement further expands Aptar Pharma’s leading respiratory portfolio Quattrii Dry Powder Inhaler (DPI) Platform. Photo credit: Cambridge Healthcare Innovations.

The global dry powder inhaler market is on a steady growth path, with a projected valuation of USD 20.83 billion in 2024. The market is expected to expand significantly, reaching USD 29.95 billion by ...